Serina Therapeutics annual capital expenditures (capex)
2017
2018
2019
2020
2022
2023
2024
2025
Serina Therapeutics Capital Expenditures (CapEx) Growth & History (SER)
Serina Therapeutics's capital expenditures (capex) was $59,000 for fiscal 2025.
View full Serina Therapeutics company overviewSerina Therapeutics annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $59,000 | $37,000 | +168.18% |
| 2024 | 2024-12-31 | $22,000 | −$482,000 | −95.63% |
| 2023 | 2023-12-31 | $504,000 | $494,318 | +5105.54% |
| 2022 | 2022-12-31 | $9,682 | — | — |
| 2020 | 2020-12-31 | $20,000 | −$621,000 | −96.88% |
| 2019 | 2019-12-31 | $641,000 | $620,000 | +2952.38% |
| 2018 | 2018-12-31 | $21,000 | $20,000 | +2000.00% |
| 2017 | 2017-12-31 | $1,000 | — | — |
Serina Therapeutics quarterly capital expenditures (capex)
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q3.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $28,000 | −$18,000 | −39.13% |
| Q1 2026 | 2026-03-31 | $25,000 | $25,000 | — |
| Q4 2025 | 2025-12-31 | $0 | −$5,000 | — |
| Q3 2025 | 2025-09-30 | $13,000 | $10,000 | +333.33% |
| Q2 2025 | 2025-06-30 | $46,000 | $46,000 | — |
| Q1 2025 | 2025-03-31 | $0 | −$14,000 | — |
| Q4 2024 | 2024-12-31 | $5,000 | — | — |
| Q3 2024 | 2024-09-30 | $3,000 | −$116,000 | −97.48% |
| Q2 2024 | 2024-06-30 | $0 | — | — |
| Q1 2024 | 2024-03-31 | $14,000 | — | — |
| Q3 2023 | 2023-09-30 | $119,000 | — | — |
| Q4 2020 | 2020-12-31 | $0 | −$295,000 | — |
| Q3 2020 | 2020-09-30 | $12,000 | −$225,000 | −94.94% |
| Q2 2020 | 2020-06-30 | $4,000 | −$102,000 | −96.23% |
| Q1 2020 | 2020-03-31 | $4,000 | $1,000 | +33.33% |
| Q4 2019 | 2019-12-31 | $295,000 | $295,000 | — |
| Q3 2019 | 2019-09-30 | $237,000 | $229,000 | +2862.50% |
| Q2 2019 | 2019-06-30 | $106,000 | $94,000 | +783.33% |
| Q1 2019 | 2019-03-31 | $3,000 | $2,000 | +200.00% |
| Q4 2018 | 2018-12-31 | $0 | — | — |
| Q3 2018 | 2018-09-30 | $8,000 | — | — |
| Q2 2018 | 2018-06-30 | $12,000 | — | — |
| Q1 2018 | 2018-03-31 | $1,000 | — | — |
Serina Therapeutics capital expenditures (capex) trends
Over the last five fiscal years, Serina Therapeutics's capital expenditures (capex) increased from $20,000 to $59,000, a change of $39,000. The latest reported quarter, Q2 2026, shows $28,000.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Serina Therapeutics source filings ↗